Prenatal cytomegalovirus, rubella, and Zika virus infections associated with developmental disabilities: past, present, and future.
Eliza Gordon-Lipkin, Alexander Hoon, Carlos A Pardo
PMID 33084055WHAT IT FOUND
Prenatal rubella, cytomegalovirus and Zika can cause developmental disability even when maternal illness is mild.
Timing matters, and hearing loss or subtle delays may appear after birth.
Key findings
01A maternal infection can cause serious developmental disability even when the mother had mild or no symptoms.
02The timing of infection changes the pattern of disability: early pregnancy is linked to structural anomalies, while later infection may cause subtler problems such as hearing loss or learning disability.
03Some consequences can be mitigated after birth, including hearing augmentation or cochlear implants for sensorineural hearing loss and early intervention for developmental delay.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is a narrative review, not an original study, so it does not test any treatment or report new patient outcomes. The paper does not describe how studies were selected, so the strength of each cited result is hard to judge. Many cited outcomes come from older epidemics or specific countries, so they may not match today's patients in all settings. The evidence on antivirals, vaccines and screening is described as under investigation, so it cannot be used to promise that a treatment will prevent disability. The review discusses SARS-CoV-2 as evolving, so it does not settle fetal risk.
Declared interests
The article is supported by NIH extramural research funding. No competing interest declaration is included in the supplied text.
The easy way to misread this
Do not treat the reported benefit of oral valganciclovir in symptomatic infants as proof that antivirals prevent disability for all exposed infants. The paper says antivirals are still under active investigation and ongoing trials are needed.